chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received on 09-OCT-2015 from a pharmacist regarding a female who received a dose of PENUMOVAX23 approximately three years earlier and received a second dose of PNEUMOVAX23 (lot # L002310, expiration date 08-JUL-2016)  0.5 ml, intramuscular, on08-OCT-2014. Pharmacist reported patient received an unspecified influenza shot in the same arm, as PNEUMOVAX23, on 08-OCT-2015. NO adverse effects were reported. No further information was provided. Additional information has been requested.
Hospitalized June 20 - 26th for questionable recurrent pneumonia (scant MRSA isolated from resp cx), administered Pneumovax afternoon of June 26th in left deltoid at time of discharge.  At time of injection, pt experienced some discomfort, and at home later that evening developed low-grade fever.  The fever progressed the next day, left shoulder pain radiated to neck/upper chest, and increased redness at injection site.  Pt presented to the ED on June 28th with fever 102.9, general malaise, WBC 15.8k, and cellulits/redness/soreness at injection site.  Vancomycin and Zosyn IV started while blood cultures pending, and admitted for management.  Cultures remained negative during hospitalization (pt was on Vantin and Bactrim DS at time of discharge), CT of shoulder revealed no abscess. Discharged with symptoms resolved, and allergy to Pneumovax entered into pt's medical record. 10/18/07-records received for DOS 6/20-6/26/07-DC DX: Pneumonia with MRSA from respiratory culture and strep antigen positive in urine sample. Hypoxemia. Reactive airway disease. Depression. Fibromyalgia. Left Otitis externa. Posttraumatic stress disorder. Polysubstance abuse, including opiates and benzodiazepines. Anxiety.  Presented to ED with fever, productive cough and shortness of breath. Difficulty since August with intermittent productive cough, night sweats and fever. Pulse oximetry 85%.
Vaccine accidentally given to patient at 87 days after patient had received passive monoclonal antibody therapy instead of after 90 days, after misreading the answer section on prep-mod. Patient appeared to have no adverse reaction. Patient was monitored for 15+ minutes by multiple nurses. Patient is under care at a skilled nursing facility and received ongoing monitoring from the staff there, but no changes were noted in the course of observation or reported by staff after this writer's monitoring period had ended, and required no further treatment related to receiving the vaccine. Alerted staff to the error, and staff stated that they had been told by another vaccinating service that they wouldn't vaccinate this patient and several others who had had the passive monoclonal antibody therapy too recently. This information wasn't shared with this vaccination service that this was the reason, and registered several patients for vaccination who were not yet outside of the 90 day window. Provided education to staff regarding this, and vaccinators refused other individuals who were registered.
lack of appetite; shortness of breath; nausea; extreme neck pain; dizziness; weakness; A spontaneous report was received from a  concerning female patient, who received Moderna's COVID-19 vaccine (mRNA-1273)  and experienced extreme neck pain, dizziness and weakness, lack of appetite and nausea, shortness of breath.  The patient's medical history, was not reported. Concomitant medications included Amoxicillin, Metronidazole, Zetia, HCTZ, Losartan, Singulair, Effexor, Calcium, Vitamin D, Aspirin.  On 17-Feb-2021, the patient received their second of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  Experienced extreme neck pain, dizziness and weakness, lack of appetite and nausea, shortness of breath. Treatment taken included Tylenol, Advil.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events,extreme neck pain, dizziness and weakness, lack of appetite and nausea, shortness of breath.  were unknown
QUITE A FEW SIDE EFFECTS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included covid 19.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, 1 total, administered on MAR-2021 for prophylactic vaccination. Batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced quite a few side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of quite a few side effects was not reported. This report was non-serious.
Patient stated it was a little painful at time of injection. She went home and took APAP. A few hours later called into the pharmacy to with chief complaint of a large amount of pain at injection site and weakness when lifting arm. She stated she had very little swelling if any and no numbness or tingling in arm. Patient was reportedly only able to lift arm with assistance and with a lot of pain. She stated pain was localized to area of injection. Pharmacy followed up with patient following morning and was told pain was still present but had decreased a little. Arm was still weak and needed assistance with lifting with no weight but was not as painful when doing so.
Pain in shoulder of the arm where shot given and then developed itchy rash. Given triamcinolone cream for the rash.
On 4/29/21 client had a very sore arm@ injection site an sore joints. These resolved by the next day. On 5/8/21 client developed chills, no wheezing, no difficulty breathing, swelling @injection site, wrist, and thumb on left side. She developed a rash of small to larger bump (1mm-8mm), red and itchy with white fluid (like head of a pimple) inside. Many were joint areas like elbow and knee. This rash spread to her entire body, showing up in patches. She saw an allergist and testing showed no allergies to vaccine ingredients. The rask has continued to come and go since it began on 5/8/21
Pfizer monovalent booster was administered on 08/31/2022 before the updated information to pause the monovalent vaccine for booster shots was received. Also, on 08/31/2022 an other booster shot of Monovalent Moderna (Batch 011B22A) 3rd shot was given to patient with below details:
MODERNA COVID-19 VACCINE EUA After the vaccine felt sleepy all day but could conduct my daily life. Left arm became sore during the night. Heartburn during the night, had trouble sleeping due to heartburn. Heartburn was stronger than my usual GERD.
RASH ALL OVER BODY; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1802072, and batch number: 1802072 expiry: UNKNOWN) .5 ml, administered on 06-MAR-2021 to Left Deltoid for prophylactic vaccination. No concomitant medications were reported. On 08-MAR-2021, the patient experienced rash all over body. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from rash all over body. This report was non-serious.
I had had this before with the first vaccine in my arm so I have to do it in my leg now but I think it's important you log people have this issue as it's extremely hard to find a pharmacy or doctor that will inject in the thigh for an adult and this is the only place I can get it. My injection site becomes inflamed so much so I can see the tissue bulking. The actual injection spot has no issues, it's just the tissue under has very strong reaction. Previously when this happened in my arm, it caused so much Inflammation that I couldn't lift my arm for over 6 months, had to get an MRI, and finally got a steroid injection that countered it. So, this vaccine does cause severe inflammation but when given in my leg it can be tolerated and is just painful,  bulky, and hot to touch but I'm confident it will go away unlike if given in my arm where causes a chain reaction of inflammation.
Painful red rash at injection site. Was painful since the vaccine was administered - unknown when the rash developed - notivied 5/14/13.
Information has been received from a consumer concerning her 10 year old son who on an unspecified date was vaccinated with a dose of MMR II (Lot # not reported). It was reported that the patient had an impaired immune system after getting MMR II. It was reported that the patient had recovered at the time of the report. The patient did not seek medical attention. No further information is available.
I?m a nurse working in a hospital. I received my 2nd vaccination on January 7th.  My husband contracted covid and tested positive 4/9/21. I tested positive today 4/13/21 after I started developing covid symptoms (congestion, cough, sore throat, headache) I?m concerned that I caught it so easily and am not ?asymptotic? as the CDC anticipated. Just thought someone should be aware of infection after full vaccination.
pt stated that a couple of hours after the vax she had arm pain and when she woke up next day she had chills, headache and felt bad.  She took her temp and it is 100.4.  Pt has not contacted her PCP at this time but will if her symptoms persist.
patient received vaccine, and within 30 seconds started feeling dizzy/lightheaded.  He was given water and his dad brought him a soda.  He was still feeling lightheaded and asked to prop his legs up on an adjacent chair, which he did, and within a minute or so was feeling better.
Patient was injected only with the adjuvant; Patient was injected only with the adjuvant; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 23-MAY-2022 Reporter's Comments:  The reporter reported the patient was injected only with the adjuvant of Shingrix. No adverse event was reported. The reporter did not consent to follow-up. No patient's identifiers provided, no lot number and expiration date provided, no vaccination date provided, unknown amount of patient that were vaccinated. Additional Supportive Information: The patient was injected only with the adjuvant of Shingrix, which led to Inappropriate preparation of medication and Inappropriate dose of vaccine administered.
MMR immunization given on 5/13/11. Rash developed around 6/5/11 described as hives all over body that come & go, itchy, did have some strawberries but never had rxn to them before. See attached office visit notes.
NEW FOOD ALLERGY; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company was unable to perform follow-up to request batch number. No concomitant medications were reported.  On an unspecified date, the subject experienced new food allergy. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of new food allergy was not reported. This report was non-serious.
Extreme soreness and limited mobility in left shoulder persisting 10 days at time of this report. Reported to nurse practitioner 6 days post vax, she prescribed Anaprox.
Pt recv vax on 4/21/98; on 4/23/98 pt exp swelling, redness, and erythema involving the entire circumference of RA from shoulder to elbow.  On 5/27/98 pt had recovered.
pt recv vax; pt very sleepy for 2 days per mom; head pounds when stands;
Severe shaking; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 11Apr2021 at 12:30 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included reactive hypoglycemia. The patient was allergic to sulfa (sulfonamide allergy). Concomitant medications included duloxetine (MANUFACTURER UNKNOWN), progesterone (MANUFACTURER UNKNOWN) and estradiol (YUVAFEM); all for an unknown indication from an unknown date and unknow if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 21Mar2021 at 12:30 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021 at 01:30, the patient experienced severe shaking that lasted about 2 hours. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures was taken as a result of the adverse events. The clinical outcome of the event severe shaking was recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Developed fever 105.6F day after receiving Hepatitis B #3. No other symptoms of viral illness. No findings on exam.
8 days after first shot in The Pfizer Covid vaccine series, I developed very horrible tinnitus. Had not been around any loud sounds. Just woke up with it roaring in my ears. Never had COVID.
Hives; Allergic; Pain; This case was reported by a consumer and described the occurrence of hives in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced hives, allergy to vaccine and pain. On an unknown date, the outcome of the hives and allergy to vaccine were unknown and the outcome of the pain was not recovered/not resolved.   It was unknown if the reporter considered the hives, allergy to vaccine and pain to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by the parents for her daughter . The age at vaccination was not reported. The reporter stated that the her daughter broke out with hives after the shot. The doctor said not get the second one. The reporter also stated that her daughter allergic to it and will be happy when pain was gone. The initial and follow-up processed together. For parents refer linked case US2021AMR190658,reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR190658:
Within 12 hours of getting PNEUMOVAX pt began getting "throbbing pain" in her rt. shoulder joint. It felt like pressure building up in the joint." Also had fever of 102.4 (measured by pt). Pt has joint pain with movement only now 15 days later partially. Pt called her doctor on 10/14/09.
Severe headaches (migraines), dizziness and light headed and abnormal gait (vertigo).  I have missed many days of work and have had to leave early on many days.
I have experienced a major change in menstraul cycle. It is very concerning now that it is going two months into the same problem. Whenever I ovulate for the month I bleed that entire  week and then still have a period the following week after it stops. This is very inconvenient for me as I don't know when I will start bleeding it's just always a random day while ovulating and now I?m concerned about my fertility and if my cycle will return to normal prior to this vaccine
Both shots hurt; face was hot all the time; Major body aches; mixed with a sudden sense I might vomit right then and there; when the vaccine was pushed in, it was a different kind of pain; This case was reported by a consumer and described the occurrence of injection site pain in a 50-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site pain, feeling hot, general body pain, nausea and injection site pain. On an unknown date, the outcome of the injection site pain, feeling hot, general body pain, nausea and injection site pain were unknown.   It was unknown if the reporter considered the injection site pain, feeling hot, general body pain, nausea and injection site pain to be related to Shingrix.  Additional details were provided as follows: The patient received the 1st shots of Shingrix and it hurt Around 36 hours after 1st dose, the patient was afflicted with major body aches and face was hot all the time. When the needle actually punctured to flesh, yowza then, when the vaccine was pushed in, it was a different kind of pain, mixed with a sudden sense that the patient might vomit right then and there. For tolerance in 2nd dose refer case US2021AMR015447.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR015452:same reporter
37 days since first dose/Didn't take the second dose because I wasn't feeling well when I was scheduled to take it; Didn't receive her second dose in May because she wasn't feeling well; Sick with congestion (coughed); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (37 days since first dose/Didn't take the second dose because I wasn't feeling well when I was scheduled to take it), VACCINATION COMPLICATION (Didn't receive her second dose in May because she wasn't feeling well) and COUGH (Sick with congestion (coughed)) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003C21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma. Concomitant products included SALBUTAMOL (ALBUTEROL HFA), FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) and MONTELUKAST for Asthma.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (37 days since first dose/Didn't take the second dose because I wasn't feeling well when I was scheduled to take it), VACCINATION COMPLICATION (Didn't receive her second dose in May because she wasn't feeling well) and COUGH (Sick with congestion (coughed)). At the time of the report, PRODUCT DOSE OMISSION ISSUE (37 days since first dose/Didn't take the second dose because I wasn't feeling well when I was scheduled to take it), VACCINATION COMPLICATION (Didn't receive her second dose in May because she wasn't feeling well) and COUGH (Sick with congestion (coughed)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.  Treatment medications was not provided.
increasing redness, warmth, discomfort;rt upper arm, elbow to axilla beginning 1 day p/vax plus chills-no fever;sx & physical findings resolved completely by day 5 p/inj was started on ATB;
This spontaneous report was received from a pharmacist referring to a patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not provided. On an unknown date in approximately 2016 (reported as two years earlier), the patient was vaccinated with the first and the second dose of GARDASIL 9 or GARDASIL (unidentified Merck HPV vaccine administered (name and lot number not provided)) for prophylaxis (strength, dose, route, frequency were not provided). The patient was in the pharmacy to receive the third dose (Inappropriate schedule of vaccine administered). No adverse effects were reported and no further information was provided.
Vials were initially stored in the fridge on 08-Jul-2022 and administered on 10-Aug-2022; HCP was not aware of any symptoms for any patient after the vaccine was given; Patient was administered with vaccine after 30-day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vials were initially stored in the fridge on 08-Jul-2022 and administered on 10-Aug-2022) and NO ADVERSE EVENT (HCP was not aware of any symptoms for any patient after the vaccine was given) in a 12-month-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 10-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine after 30-day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vials were initially stored in the fridge on 08-Jul-2022 and administered on 10-Aug-2022) and NO ADVERSE EVENT (HCP was not aware of any symptoms for any patient after the vaccine was given). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine after 30-day use by date), PRODUCT STORAGE ERROR (Vials were initially stored in the fridge on 08-Jul-2022 and administered on 10-Aug-2022) and NO ADVERSE EVENT (HCP was not aware of any symptoms for any patient after the vaccine was given) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (HCP was not aware of any symptoms for any patient after the vaccine was given) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with vaccine after 30-day use by date) and PRODUCT STORAGE ERROR (Vials were initially stored in the fridge on 08-Jul-2022 and administered on 10-Aug-2022).    No concomitant medications were reported.  It was reported that the vial had not undergone any temperature excursions.  No treatment medications were reported.
About 10-24 hours after the injection, I began to develop itchy red bumps on my core (back, chest, abdomen primarily). I did not have any reaction at the injection site or anywhere on my left arm. The bumps are somewhat raised and rough and itch on and off throughout the day. It?s a mild itch most of the time.  As of now, it?s been 1 week since my first injection and the bumps are still prevalent and itchy but not getting worse.  I can?t be 100% sure it?s related to the vaccine but wanted to report it since skin reactions are known to occur in some people.
administered first dose of gardasil 9 series on an unspecified date over a year ago . the pateint is in the office on 6/10/2019 to have the second dose administered; no adverse effect; This spontaneous report was received from a nurse refers to a 26-year-old patient of unknown gender. Pertinent medical history, drug reactions or allergies were not reported. On an unknown date (reported as over 1 year ago), the patient was vaccinated with first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (route, frequency, lot # and expiry date not reported) for prophylaxis. It was mentioned that the patient was in the office on 10-JUN-2019 to be administered with the second dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9). No adverse effects were reported.